Pharma BD Deal Intelligence
Novartis AG / Gyroscope Therapeutics
2021 · Acquisition/Merger · $1.5B · Complete
Announcement Sentiment
88
Strongly positive
Outcome Score
23
Did not work — the deal failed to deliver.
Novartis acquired Gyroscope Therapeutics for $1.5B for gene therapy for retinal diseases.
Key facts
- Announced Dec 22, 2021
- Closed Feb 23, 2022
- Deal value $1.5B
- Deal type Acquisition/Merger
- Therapeutic area Gene Therapy, Ophthalmology
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals